LEXICON PHARMACEUTICALS, INC. ($LXRX)
Filing Information
| Accession Number | 0001193125-26-037644 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
24,305,607
Total Value
$54,984,433.40
P&L
-28.4% ($15,609,349.87)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Grant/Award | 18,553,846 | $1.30 | $24,119,999.80 | 154,734,327 | Indirect | See Footnotes | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Grant/Award | 3,846,154 | $1.30 | $5,000,000.20 | 7,362,368 | Indirect | See Footnotes | View Details | |
Director | Common Stock | โ | Feb 2, 2026 | Purchase | 1,538,462 | $1.30 | $2,000,000.60 | 1,538,462 | Indirect | See Footnotes | View Details | |
Director | Series B Convertible Preferred Stock | โ | Feb 2, 2026 | Grant/Award | 367,145 | $65.00 | $23,864,432.80 | 367,145 | Indirect | See Footnotes | View Details |